Reports Q2 revenue $382.46M, consensus $375.03M. “We delivered better-than-expected financial performance in the second quarter, with our top-and-bottom line results exceeding the high-end of our forecast,” said Fred P. Lampropoulos, Merit’s Chairman and Chief Executive Officer. “We have increased our 2025 revenue and non-GAAP earnings per share guidance to reflect our stronger-than-expected first half financial results and our updated profitability expectations for the balance of the year. Specifically, we believe we can deliver higher non-GAAP gross and non-GAAP operating margins on a year-over-year basis in 2025, largely due to our currently projected impact of implemented trade policies and related actions by the U.S. and other countries since our first quarter report.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical management to meet with Barrington
- Is MMSI a Buy, Before Earnings?
- Piper Sandler Says These 2 Stocks Are Top Picks for the Second Half of 2025
- Buy Rating for Merit Medical Systems Driven by WRAPSODY Product Launch and Strategic Pricing
- Merit Medical confirms Wrapsody pass-through denied, says Wells Fargo